- Report
- January 2025
- 175 Pages
Global
From €3985EUR$4,490USD£3,461GBP
- Report
- January 2025
- 175 Pages
Global
From €3985EUR$4,490USD£3,461GBP
- Report
- August 2025
- 188 Pages
Global
From €3147EUR$3,545USD£2,733GBP
€3496EUR$3,939USD£3,036GBP
- Report
- October 2025
- 285 Pages
Global
From €5193EUR$5,850USD£4,509GBP
- Clinical Trials
- July 2025
- 80 Pages
Global
From €1775EUR$2,000USD£1,542GBP
- Drug Pipelines
- April 2025
- 90 Pages
Global
From €1331EUR$1,500USD£1,156GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1331EUR$1,500USD£1,156GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1110EUR$1,250USD£964GBP
- Report
- September 2025
- 144 Pages
Global
From €2662EUR$2,999USD£2,312GBP
- Report
- March 2025
- 147 Pages
Global
From €2662EUR$2,999USD£2,312GBP
- Report
- April 2025
- 185 Pages
Global
From €3994EUR$4,500USD£3,469GBP
- Report
- March 2025
- 150 Pages
Global
From €3417EUR$3,850USD£2,968GBP
€4305EUR$4,850USD£3,739GBP
- Report
- September 2025
- 150 Pages
Global
From €3950EUR$4,450USD£3,430GBP
- Report
- November 2024
- 203 Pages
Global
From €3950EUR$4,450USD£3,430GBP
- Report
- October 2025
- 382 Pages
Global
From €5193EUR$5,850USD£4,509GBP
- Report
- July 2025
- 350 Pages
Global
From €4393EUR$4,949USD£3,815GBP
- Report
- June 2025
- 200 Pages
Global
From €2476EUR$2,789USD£2,150GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2476EUR$2,789USD£2,150GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2476EUR$2,789USD£2,150GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2476EUR$2,789USD£2,150GBP

The Macrolide Antibiotic market is a segment of the Infectious Diseases Drugs market. Macrolides are a class of antibiotics used to treat a wide range of bacterial infections, including respiratory tract infections, skin infections, and sexually transmitted diseases. Macrolides are generally well-tolerated and have fewer side effects than other antibiotics. They are also effective against drug-resistant bacteria, making them an important tool in the fight against antibiotic resistance. Macrolides are available in both oral and intravenous formulations, and are often used in combination with other antibiotics.
The Macrolide Antibiotic market is highly competitive, with a number of large pharmaceutical companies offering products. Some of the major players in the market include Pfizer, Merck, GlaxoSmithKline, Sanofi, AstraZeneca, and Novartis. Show Less Read more